Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Just Released Its Yearly Results And Analysts Are Updating Their Estimates [Yahoo! Finance]
Ionis Pharmaceuticals, Inc. (IONS)
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ionispharma.com
Company Research
Source: Yahoo! Finance
The results were impressive, with revenues of US$788m exceeding analyst forecasts by 24%, and statutory losses of US$2.56 were likewise much smaller than the analysts had forecast. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year. See our latest analysis for Ionis Pharmaceuticals After the latest results, the consensus from Ionis Pharmaceuticals' 21 analysts is for revenues of US$644.8m in 2024, which would reflect a considerable 18% decline in revenue compared to the last year of performance. Losses are forecast to balloon 61% to US$4.03 per share. Before this latest report, the consensus had been expecting revenues of US$635.3m and US$3.86 per share in losses. So it's pretty clear consensus is mixed on Ionis Pharmaceutica
Show less
Read more
Impact Snapshot
Event Time:
IONS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IONS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IONS alerts
High impacting Ionis Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
IONS
News
- WAYLIVRA (Volanesorsen) for Lipodystrophy Research Report 2024: Market Size, Forecasts, and Emerging Insight 2019-2032 - Focus on United States, Germany, France, Italy, Spain, United Kingdom, & Japan [Yahoo! Finance]Yahoo! Finance
- Ionis Publishes 2023 Corporate Responsibility Report [Yahoo! Finance]Yahoo! Finance
- Ionis Publishes 2023 Corporate Responsibility ReportPR Newswire
- n-Lorem Foundation Partners with Hongene Biotech Corporation to Support the Discovery of Personalized ASO Medicines for Nano-rare Patients [Yahoo! Finance]Yahoo! Finance
- Ionis to hold first quarter 2024 financial results webcastPR Newswire
IONS
Earnings
- 2/21/24 - Beat
IONS
Sec Filings
- 4/25/24 - Form ARS
- 4/25/24 - Form DEFA14A
- 4/25/24 - Form DEF
- IONS's page on the SEC website